Article - 19 Nov 2003
University of California, Berkeley chemists have used silver nanowires as key elements of a sensitive explosives detector. Posted September 11 2003
News - 9 Aug 2007
Starpharma today announced that its wholly owned subsidiary Dendritic Nanotechnologies Inc (DNT) will develop its proprietary technology to purify water following the award of a contract with the US...
News - 23 Aug 2007
Oncologix Tech Inc. announced today that it has qualified a new design of its Oncosphere product in response to the "leaching" problem found in its previous design. The improved design was...
Article - 25 Aug 2005
As dendrimers offer manufacturers the prospect of making vast profits in a number of different industry areas, the race to register patents for dendrimers has been fierce. The story of how Dendritic...
News - 21 Jul 2014
New technology under development at UC Berkeley could soon give bomb-sniffing dogs some serious competition.
A team of researchers led by Xiang Zhang, UC Berkeley professor of mechanical...
News - 4 Nov 2009
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the signing of a research and collaboration agreement between its wholly owned US subsidiary, DNT Inc, and a prominent, US-based...
News - 22 Apr 2008
Starpharma Holdings Ltd today announced the first commercial product launch based on its Priostar® dendrimer technology.
The product, a research reagent kit called NanoJuiceTM Transfection Kit...
News - 28 Jun 2010
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) and the Monash Institute of Pharmaceutical Sciences (MIPS) have been awarded an Australian Research Council funding grant for the purpose of...
News - 22 Sep 2009
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced that it has received notification of the grant in the US of a key patent specifically relating to the use of SPL7013 to protect...
News - 3 Aug 2009
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the results of its clinical trial demonstrating that VivaGel® retains antiviral activity against human immunodeficiency virus...